Latest News
Latest News
Beximco Pharma Announces Third Quarter Financial Statements, 2011
We are pleased to present the un-audited Financial Statements of Beximco Pharmaceuticals Ltd.for the third quarter ended September 30, 2011 as per Securities and Exchange CommissionNotification No. SEC/CMRRCD/2008-183/Admin/03-34 dated September 27, 2009.
Beximco Phrama joins Mobile Alliance for Maternal Action (MAMA)
BEXIMCO PHARMACEUTICALS LTD.
3rd August, 2011
Beximco Phrama joins Mobile Alliance for Maternal Action (MAMA)
Beximco Pharmaceuticals Limited (“Beximco Pharma” or the “Company”) has joined Mobile Alliance for Maternal Action (MAMA) in Bangladesh, an innovative coalition to use mobile phones for delivering life-saving health information to expectant and new mothers in Bangladesh. The Company has signed an agreement with D.Net, a social enterprise and the Coalition Coordinator of the MAMA initiative, at a simple ceremony held at Beximco Pharma’s Corporate Office on July 19, 2011. Ministry of Health and Family Welfare (MoHFW) and Access to Information (A2I) Programme at Prime Minister's Office are official partners of the initiative.
Read more: Beximco Phrama joins Mobile Alliance for Maternal Action (MAMA)
EU GMP Certificate Received
BEXIMCO PHARMACEUTICALS LTD.
21 July 2011
EU GMP Certificate Received
Beximco Pharmaceuticals Limited (“BPL” or “the Company”; AIM Symbol: BXP), the fast-growing manufacturer of generic pharmaceutical formulation products, active pharmaceutical ingredients and intravenous fluids, today announces that it has received GMP (“Good Manufacturing Practices”) accreditation from the Regulatory Authority of Austria for its oral solid (tablets and capsules) and sterile eye drop facilities at Tongi, Dhaka. The approval received from the Austrian Drug Authority will be recognized throughout the European Union (EU) by Mutual Recognition between the member countries. This is a significant milestone for the company which should facilitate exports to the lucrative generic drug markets of Europe.
Half Year Results - 2011
BEXIMCO PHARMACEUTICALS LTD.
29th July, 2011
Half Year Results - 2011
Beximco Pharmaceuticals Limited ("BPL" or "Company"; AIM Symbol: BXP) today announces its results for the half year to 30 June 2011.
Highlights
Half year financial highlights
- Net sales increased by 22.7% to Bangladesh Taka ("BDT") 3,642.3m / £30.5m (2010: BDT 2,968.7 m / £27.3m)
- Domestic sales increased 22.8% to BDT 3,468.8m / £29.1m (H1 2010: BDT 2,825.9m / £26.0m)
- Export sales increased 21.6% to BDT 173.5m / £1.5m (H1 2010: BDT 142.7m / £1.3m)
- Profit before tax increased by 9.6% to BDT 764.5m / £6.4m (H1 2010: BDT 697.3m / £6.4m)
- EPS increased by 7.9% to BDT 2.72 / 2.3 pence (2010: BDT 2.52 / 2.3 pence)
Second quarter highlights
- Net sales increased by 20% to BDT 1,970.6m / £16.5m (2010: BDT1,642.0m / £15.1m)
- Profit before tax increased by 21.6% to BDT 461.4m / £3.9m (2010: BDT 379.3m / £3.5m)
Operational highlights
- 10 new products registered in overseas markets
- Launched 21 new products across different therapeutic classes
- Plant and Machinery for the New MDI (Metered Dose Inhaler) facility installed and commissioned, trial production scheduled August 2011
Post-period events
- Received GMP (Good Manufacturing Practices) accreditation from Austrian regulatory authority for Oral Solid and Sterile Eye Drop Facilities
- Approval recognized throughout European Union (EU)
Financial Reports: First Quarter 2011
We are pleased to present the un-audited Financial Statements of Beximco Pharmaceuticals Ltd.for the first quarter ended March 31, 2011 as per Securities and Exchange Commission Notification No. SEC/CMRRCD/2008-183/Admin/03-34 dated September 27, 2009.
Open/ Download
Price Sensitive Information
This is for information of the valued Shareholders of the Company that the Board of Directors in their meeting held on 28 April, 2011 at 3.30 p.m. has decided in regard to 35th Annual General Meeting (AGM) of the Shareholders of the Company for the year ended 31st December, 2010 as follows:
Beximco Announces Financial Results for the Third Quarter of 2010
We are pleased to present the un-audited Financial Statements of Beximco Pharmaceuticals Ltd. for the third quarter ended September 30, 2010 as per Securities and Exchange Commission Notification No. SEC/CMRRCD/2008-183/Admin/03-34 dated September 27, 2009
Press Releases 28 October 2010
Beximco Announces Financial Results for the First Quarter of 2010
Beximco Pharmaceuticals Limited (“BPL” or “Company”; AIM Symbol: BXP) today announces its unaudited financial results for the three month period ended 31 March 2010. The information set out below has been released to the Dhaka and Chittagong Stock Exchanges in compliance with the requirements from the Bangladesh SEC.
Press Releases 14 May 2010
Notice of the thirty-fourth Annual General Meeting
Notice is hereby given that the THIRTY-FOURTH ANNUAL GENERAL MEETING of the Shareholders of Beximco Pharmaceuticals Limited will be held on Tuesday, the 15th June, 2010 at 10.00 a.m. at Beximco Industrial Park, Sarabo, Kashimpur, Gazipur to transact the following business:
Price Sensitive Information
This is for information of the valued Shareholders of the Company that the Board of Directors in their meeting held on 29 April, 2010 at 3.30 p.m. has decided in regard to 34th Annual General Meeting (AGM) of the Shareholders of the Company for the year ended 31st December, 2009 the followings:
Page 1 of 4
